ASHLEY COLLINS: Open Payments
NPI 1679162366 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$216 in 9 payments from 6 companies in 2025. Trend: 2023 $923 · 2024 $669 · 2025 $216
Food & beverage: $216
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $74 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $33 |
| Novo Nordisk Inc | 1 | $22 |
| ABBVIE INC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: INGREZZA, Auvelity, Ozempic, VRAYLAR, BREZTRI.
Industry payments across IN — which companies pay providers there.
